Avex Inc. will absorb its wholly-owned subsidiary Avex Healthcare Empower LLC as of April 1, 2026, aiming to streamline its organizational efficiency. The impact on consolidated performance is expected to be minimal.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7860","jir_company_name":"Avex Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/7860-20260305-01.pdf","jir_short_summary":"Avex Inc. will absorb its wholly-owned subsidiary Avex Healthcare Empower LLC as of April 1, 2026, aiming to streamline its organizational efficiency. The impact on consolidated performance is expected to be minimal.","jir_summary":"### Overview of the Merger\nAvex Inc. has resolved to absorb its wholly-owned subsidiary Avex Healthcare Empower LLC effective as of April 1, 2026. This is a simplified absorption-type merger, and therefore no shareholders' meeting will be held for the approval of the merger agreement. The purpose of this merger is to consolidate management resources and promote efficient organizational operations within the group. The dissolving company has neither issued stock acquisition rights nor bonds with stock acquisition rights, and no new shares or cash allocations will be made.\n\n### Impact on Shareholders and Business Performance\nFollowing this merger, there will be no changes to Avex Inc.'s name, location, representative, capital stock, or fiscal year-end. As this is an absorption-type merger of a wholly-owned subsidiary, the impact on consolidated financial results is expected to be minimal. For the fiscal year ending March 2025, consolidated net sales were 131,691 million yen, operating income was \u25b31,819 million yen, and net income attributable to owners of parent was 1,138 million yen. The dissolving company's standalone net sales were 22 million yen, operating loss was \u25b341 million yen, and net loss was \u25b329 million yen.","jir_financial_highlights":"Capital Stock (Surviving Company): 4,836 million yen (Unknown)\nCapital Stock (Dissolving Company): 30 million yen (Unknown)\nNet Sales (Surviving Company, standalone): 22 million yen (Unknown)\nOperating Income (Surviving Company, standalone): \u25b341 million yen (Unknown)\nNet Income Attributable to Owners of Parent (Surviving Company, standalone): \u25b329 million yen (Unknown)\nNet Sales (Consolidated): 131,691 million yen (Unknown)\nOperating Income (Consolidated): \u25b31,819 million yen (Unknown)\nNet Income Attributable to Owners of Parent (Consolidated): 1,138 million yen (Unknown)","jir_category":"","jir_hashtags":"#AvexInc, #CorporateRestructuring, #JapaneseStocks","jir_key_figures":"Merger Effective Date: Scheduled April 1, 2026\nSurviving Company Capital Stock: 4,836 million yen\nDissolving Company Capital Stock: 30 million yen","jir_meta_title":"Avex Inc. to Execute Absorption-Type Merger of Wholly-Owned Subsidiary on April 1, 2026","jir_meta_description":"Avex Inc. will absorb its wholly-owned subsidiary Avex Healthcare Empower LLC effective April 1, 2026, aiming to consolidate management resources and improve organizational efficiency. The impact on consolidated earnings is expected to be minimal.","jir_og_title":"Notice of Absorption-Type Merger of Wholly-Owned Subsidiary by Avex Inc.","jir_og_description":"Effective April 1, 2026, Avex Inc. will absorb its wholly-owned subsidiary to promote efficient organizational operations. The impact on consolidated financial performance is expected to be minimal.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17242,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-33488","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n